Rheumatic Complications of Immune Checkpoint Inhibitors
- PMID: 33589099
- DOI: 10.1016/j.mcna.2020.09.009
Rheumatic Complications of Immune Checkpoint Inhibitors
Abstract
Immune checkpoint inhibitors activate the immune system to combat cancer. In doing so, however, they can cause immune-related adverse events (irAEs), including rheumatic syndromes, such as inflammatory arthritis, polymyalgia rheumatica, and myositis. This article reviews rheumatic irAEs that may be encountered in the general medicine practice and provides guidance to support prompt recognition, referral, and treatment of these patients.
Keywords: Cancer; Disease-modifying antirheumatic drugs; Immune checkpoint inhibitors; Immune-related adverse events; Myositis; Polymyalgia rheumatica; Rheumatoid arthritis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no commercial or financial conflicts of interest. N. Ghosh is supported by an NIH grant as a Master’s degree student in Clinical and Translational Investigation at Weill Cornell Medicine: NIH/NCATSUL1-TR-0023849.
Similar articles
-
Rheumatic Complications of Immune Checkpoint Inhibitors.Rheum Dis Clin North Am. 2022 May;48(2):411-428. doi: 10.1016/j.rdc.2022.02.002. Rheum Dis Clin North Am. 2022. PMID: 35400368 Review.
-
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327425 Free PMC article.
-
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications.Arthritis Rheumatol. 2021 Apr;73(4):553-565. doi: 10.1002/art.41587. Epub 2021 Mar 5. Arthritis Rheumatol. 2021. PMID: 33186490 Free PMC article. Review.
-
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events.Rheum Dis Clin North Am. 2024 May;50(2):181-199. doi: 10.1016/j.rdc.2024.01.003. Epub 2024 Feb 22. Rheum Dis Clin North Am. 2024. PMID: 38670720 Review.
-
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13. Eur J Cancer. 2018. PMID: 30439628
Cited by
-
Uncovering the flip side of immune checkpoint inhibitors: a comprehensive review of immune-related adverse events and predictive biomarkers.Int J Biol Sci. 2024 Jan 1;20(2):621-642. doi: 10.7150/ijbs.89376. eCollection 2024. Int J Biol Sci. 2024. PMID: 38169638 Free PMC article. Review.
-
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy.Front Med (Lausanne). 2021 Nov 4;8:762247. doi: 10.3389/fmed.2021.762247. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34805229 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical